Dry Eye Under China's Dynamic COVID-zero Strategy
Dry Eye Symptoms of University Students Under China's Dynamic COVID-zero Strategy: A Comparison Between the Epidemic and Non-epidemic Areas
1 other identifier
observational
1,807
1 country
1
Brief Summary
To compare the prevalence of dry eye symptoms and to investigate the association of the risk factors with the dry eye symptomatology among university students in the epidemic and non-epidemic areas of China under the COVID-zero strategy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 25, 2022
CompletedFirst Submitted
Initial submission to the registry
July 23, 2022
CompletedFirst Posted
Study publicly available on registry
July 27, 2022
CompletedJuly 27, 2022
July 1, 2022
2 months
July 23, 2022
July 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
A score of ocular surface disease index (OSDI)questionnaire
Ocular surface disease index (OSDI)questionnaire : (1) OSDI: ≤12 (no DED symptoms), 13 ≤ d ≤ 22 (mild DED symptoms), 23 ≤ d ≤ 32 (moderate DED symptoms), and ≥33 (severe DED symptoms).
DAY 0
A score of GAD-7 questionnaire
GAD-7 questionnaire: (1) 0 \< GAD-7 ≤ 4 (normal), 5 ≤ GAD-7 ≤ 9 (mild anxiety), 10 ≤ GAD-7 ≤ 13 (moderate anxiety), 14 ≤ GAD-7 ≤ 18 (moderate and severe anxiety), and 19 ≤ GAD-7 ≤ 21 (severe anxiety).
DAY 0
A score of PHQ-9 questionnaire
PHQ-9 questionnaire: (1) 0 \< PHQ-9 ≤ 4 (normal), 5 ≤ GAD-7 ≤ 9 (mild depression), 10 ≤ GAD-7 ≤ 14 (moderate depression), 15 ≤ GAD-7 ≤ 19 (moderate and severe depression), and 20 ≤ GAD-7 ≤ 27 (severe depression).
DAY 0
Secondary Outcomes (3)
A score of UCLA Loneliness Scale questionnaire
DAY 0
Students' increased use of mobile phones
DAY 0
Frequency of student sports
DAY 0
Study Arms (2)
Epidemic area (Nanchang, Nanchang university)
Non-epidemic area (Kaifeng, Henan university)
Eligibility Criteria
The subjects of the study are students from Nanchang University and Henan University.
You may qualify if:
- College students with age ≥18 years
- No other medication history in recent 2 weeks;
- Have high compliance and are willing to fill in the questionnaire on time
You may not qualify if:
- routinely using artificial tears and Other eye drops;
- taking any medication that could interfere with the results of the study;
- with any history of eye surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yifeng Yulead
Study Sites (1)
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Deputy chief physician of Ophthalmology center of the Second Affiliated Hospital of Nanchang University
Study Record Dates
First Submitted
July 23, 2022
First Posted
July 27, 2022
Study Start
March 20, 2022
Primary Completion
May 20, 2022
Study Completion
May 25, 2022
Last Updated
July 27, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share